17 studies found for:    "Congenital cytomegalovirus"
Show Display Options
Rank Status Study
1 Not yet recruiting Investigation of Six Weeks of Oral Valganciclovir Therapy in Infants and Children With Congenital Cytomegalovirus Infection and Hearing Loss
Conditions: Congenital Cytomegalovirus;   Hearing Loss
Interventions: Drug: Valcyte (Valganciclovir hydrochloride) Powder for oral solution;   Drug: Placebo
2 Terminated Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
3 Recruiting Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
4 Recruiting A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Conditions: Congenital Cytomegalovirus Infection;   Maternal Cytomegalovirus Infection
Intervention: Drug: CMV hyperimmune globulin
5 Not yet recruiting Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening
Condition: Congenital Cytomegalovirus Infection
Intervention: Other: CMV PCR
6 Recruiting Prognostic Value of Neonatal Markers (Clinical, Imaging and Biological) for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus (CMV) in Utero
Condition: Congenital Cytomegalovirus Infection
Intervention: Other: Standardized test report
7 Completed Valganciclovir in Congenital CMV Infants
Condition: Cytomegalovirus Infections
Interventions: Drug: Valganciclovir;   Drug: Ganciclovir
8 Recruiting Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
Condition: Cytomegalovirus Congenital Infection
Intervention: Biological: standard intravenous immunoglobulin
9 Completed Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease
Condition: Cytomegalovirus Infections
Intervention: Drug: SDZ MSL-109
10 Completed A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.
Condition: Cytomegalovirus Infections
Intervention: Drug: ganciclovir
11 Active, not recruiting
Has Results
Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections
Condition: Cytomegalovirus Infection
Interventions: Drug: Placebo;   Drug: Valganciclovir
12 Completed Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
Condition: Cytomegalovirus Infections
Intervention: Drug: ganciclovir
13 Terminated In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir
Conditions: Viral Disease;   Cytomegalovirus Infection
Interventions: Drug: Valacyclovir (ZELITREX);   Drug: Placebo
14 Recruiting Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus
Conditions: Cytomegalovirus Infections;   Pregnancy;   Behavior
Intervention: Behavioral: Educational Intervention
15 Completed Neonatal CMV-Ganciclovir Follow-up Study
Condition: Cytomegalovirus Infections
Intervention:
16 Completed The Benefits Feasibility and Acceptability of Extended Screening Testing in Newborn Babies Who Are Referred for Further Hearing Assessment
Conditions: Hearing Loss;   Cytomegalovirus
Intervention: Other: Screening urine and saliva tests for congenital Cytomegalovirus
17 Unknown  Genotyping of Cytomegalovirus From Patients in Israel
Condition: Cytomegalovirus Infections
Intervention:

Indicates status has not been verified in more than two years